With the recent trial launch of the federal Medicare GLP-1 Bridge program, American medicine has officially stepped into a ...
A new survey finds the use of GLP-1 weight loss drugs at a new high even as the U.S. obesity rate shows a ‘meaningful’ decline.
Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...
New research indicates weight-loss drugs offer few quality-of-life benefits after one year. These medications often lead to ...
Body Mass Index (BMI) has long been used in public health and clinical settings as a simple tool to classify an individual's ...
Analysis of 12 indicators including asthma, obesity and vaccination finds child health is ‘national embarrassment’ ...
The Consistent Body Mass Index (CBMI) offers a promising alternative to traditional BMI, aligning with waist-to-height ratio ...
Edgar Wright's adaptation of Stephen King's 'The Running Man' is gaining traction on streaming platforms, ranking high on ...
A nationwide ecological analysis of Italian regions found that aging and extreme longevity indicators rose steadily from 1982 ...
What happens when something we've been told as scientific fact turns out to be absolutely false? In Jennifer Isenhart's ...
The parents of a 7-year-old boy who died in Michigan last year are facing murder and child abuse charges, court documents say.
The weight-loss boom has created one of the market's biggest opportunities — and some of its most punishing failures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results